Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P0CE71
UPID:
OCM2_HUMAN
Alternative names:
-
Alternative UPACC:
P0CE71; P32930; Q6ISI5; Q75MW0
Background:
Putative oncomodulin-2, encoded by the gene with accession number P0CE71, represents a novel protein of interest in the field of molecular biology. Its precise role and mechanism of action remain to be fully elucidated, yet its designation suggests a potential involvement in oncogenic processes. The protein's structure and biochemical pathways, while not completely understood, are the subject of ongoing research.
Therapeutic significance:
Understanding the role of Putative oncomodulin-2 could open doors to potential therapeutic strategies. Its hypothesized involvement in cancer biology makes it a promising target for drug discovery efforts aimed at developing novel oncology treatments.